Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP459968.RAkKTHmt2SDhWytIN9YYpDGsGzh5QwC92Z19-NDFt8UcQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP459968.RAkKTHmt2SDhWytIN9YYpDGsGzh5QwC92Z19-NDFt8UcQ130_assertion type Assertion NP459968.RAkKTHmt2SDhWytIN9YYpDGsGzh5QwC92Z19-NDFt8UcQ130_head.
- NP459968.RAkKTHmt2SDhWytIN9YYpDGsGzh5QwC92Z19-NDFt8UcQ130_assertion wasGeneratedBy ECO_0000203 NP459968.RAkKTHmt2SDhWytIN9YYpDGsGzh5QwC92Z19-NDFt8UcQ130_provenance.
- NP459968.RAkKTHmt2SDhWytIN9YYpDGsGzh5QwC92Z19-NDFt8UcQ130_assertion wasDerivedFrom befree-2016 NP459968.RAkKTHmt2SDhWytIN9YYpDGsGzh5QwC92Z19-NDFt8UcQ130_provenance.
- NP459968.RAkKTHmt2SDhWytIN9YYpDGsGzh5QwC92Z19-NDFt8UcQ130_assertion SIO_000772 15368334 NP459968.RAkKTHmt2SDhWytIN9YYpDGsGzh5QwC92Z19-NDFt8UcQ130_provenance.
- NP459968.RAkKTHmt2SDhWytIN9YYpDGsGzh5QwC92Z19-NDFt8UcQ130_assertion evidence source_evidence_literature NP459968.RAkKTHmt2SDhWytIN9YYpDGsGzh5QwC92Z19-NDFt8UcQ130_provenance.
- NP459968.RAkKTHmt2SDhWytIN9YYpDGsGzh5QwC92Z19-NDFt8UcQ130_assertion description "[Individuals having the genotype of the arginine/glutamine polymorphism at codon 399 in the XRCC1 gene (R399) showed a nonsignificant increased risk of breast carcinoma compared with those without (OR, 1.4; 95% CI, 0.7-2.7), and a nonsignificant decreased risk against a subsequent thyroid carcinoma (OR, 0.6; 95% CI, 0.2-1.6).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP459968.RAkKTHmt2SDhWytIN9YYpDGsGzh5QwC92Z19-NDFt8UcQ130_provenance.